CTRI/2017/08/009518已完成2 期
Clinical Evaluation of Efficacy of Mahatriphaladi Ghritam and Anu Taila Nasyam in the Management of Computer Vision Syndrome
Centrral Council for Research in Ayurvedic Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i)Patients of either sex aged between 18 to 35 years
- •ii)Patients having minimum three symptoms of Computer Vision Syndrome (Eye strain and fatigue,Headache, blurred vision, Dry and irritated eyes, Neck and shoulder pain, Double vision,Redness of eyes, Burning eyes, excessive tearing and photophobia)
- •iii)Minimum 3 hours daily exposure to any type of Video Display Terminals like Desktop, Laptop or both
- •iv)Minimum 1 year exposure to any type of above mentioned VDTs
- •v)Willing patients with informed consent obtained.
排除标准
- •i)Age less than 18 years and more than 35 years
- •ii)Presence of signs and symptoms due to direct physiological effects of substance (medication, drug abuse) or presence of any general health problems (like Hypothyroidism)
- •iii)Presence of any infectious conditions of the eye, Cataract, Glaucoma, stye, any fundus pathology.
- •iv)Patients having Cervical spondylosis or spasm of trapezius muscle.
- •v)History of any surgical intervention with reference to the eye
- •vi)Patient with h/o Migraine
- •vii)Patients with h/o Hypertension or Diabetes Mellitus
- •viii)Patients with evidence of malignancy.
- •ix)Patients on prolonged ( 6 weeks) medication withcorticosteroids, antidepressants, anticholinergics, oral Contraceptive pills, etc.or any other drugs that may have an influence on the outcome of the study.
- •x)Patients with major systemic illness
- •xi)Patients with concurrent serious hepatic disorder defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine1.2mg/dL), Known case of Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]),
- •or any other condition that may jeopardize the study.
- •xii)Smokers/ Alcoholics and/or drug abuser
- •xiii)H/o hypersensitivity to any of the trial drug or their ingredients
- •xiv)Pregnant / lactating woman.
- •xv) Patients who have completed participation in any other
- •clinical trial during the past six (06) months
- •xvi) Any other condition which the Principal Investigator thinks may jeopardize the study.
研究者
相似试验
已完成
2 期
A comparative clinical evaluation of Mahatriphala ghrita in the management of the chemo toxicity in head & neck cancerCTRI/2022/07/043896Government Akhandanad Ayurveda College80
招募中
2 期
A clinical study to see the effect of an Ayurvedic formulation in the treatment of Dry Eyes.CTRI/2012/03/002532Central Council for Research in Ayurvedic Sciences CCRAS150
招募中
2 期
A clinical study to see the effect of an Ayurvedic formulation in the treatment of Dry EyesCTRI/2012/05/002639Department of AYUSH Ministry of Health Family Welfare Government of India150
招募中
1 期
A Clinical Trial to study the Combined Effect of Mahatriphla Ghrita with Ayurvedic Therapy patients with Adhimantha (primary open angle glaucoma)CTRI/2022/05/042635Patanjali Bhartiya Ayurvigyan evam Anusandhana Sansthana Haridwar
已完成
2 期
A clinical study to see the effect of an Ayurvedic formulation in the treatment of Conjunctivitis.CTRI/2012/01/002375Department of AYUSH Ministry of Health Family Welfare Government of India150